Chen said that there are still many other areas in whi

ch the US and China can work together.There are some types of cancer, including liver cancer and stomach canc

er, that are more common in China but are rare in the US,” he said, adding that cooperation on research for those canc

ers can help the US improve understanding of them and help China develop new drugs faster.

Chen said the potential for China’s cancer drug market is huge and dynamic. The market is projected to reach $30 billi

on by the year 2024, according to a recent report by US company Research and Markets.

Lung, breast and stomach cancer dominate the anti-cancer d

rug market in China and are expected to do so in the near future, according to the report.

vtxkf.cn